Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 15 results for "tianjin medical university cancer ins..."

Radiation-induced heart disease in lung cancer radiotherapy: A...

bDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China cDepartment of Therapeutic Radiology, Yale University, New Haven, CT, USA. Correspondence: Ping Wang, Department of Radiation Oncology, ... Medicine - Wolters Kluwer Health, 3 weeks ago

2 images for "tianjin medical university cancer institute and hospital"

Njbiz, 2 months ago
World Economic Forum, 3 months ago
Medical News Today

Researchers describe how tumors recruit and use stem cells to support tumor growth and progression

A new study has identified a mechanism used by tumors to recruit stem cells from bone and convert them into cancer-associated fibroblasts (CAFs) that facilitate tumor progression. This work, which pinpoints the specific biochemical pathways and cell ...
 Medical News Today1 month ago Research could lead to new therapeutic targets for suppressing tumor growth  News-Medical.Net1 month ago

A look at Premier Li's efforts to promote medical reform

In this year's government work report, Premier Li Keqiang stressed coordinated reform of medical care, insurance and drugs, and made great effort to solve difficulties in the process. Medical big data Enhancing the development of medical big ...
 China Government2 months ago

Molecules, Vol. 21, Pages 1616: Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms

Open Access Article Molecules 2016 , 21 (12), 1616; doi:10.3390/molecules21121616 (registering DOI) RuixueRan 1,† , ChunzeZhang 2,† , RongshanLi 1 , BoweiChen 1 , WeihuaZhang 2 , ZhenyingZhao 3 , ZhiweiFu 4 , ZuoDu 4 , ...
 MDPI1 week ago IJMS, Vol. 17, Pages 1718: Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells  MDPI1 month ago

Week In Review: Beijing's BeiGene Raises $185 Million For Clinical Trial Program

Deals and Financings BeiGene (NASDAQ: BGNE ), a Beijing novel oncology biopharma, completed a $200 secondary offering last week, up from its initial target of $150 million. The $200 million included $15 million from selling shareholders. In ...
 Seeking Alpha1 week ago

PolyU Study Finds Hong Kong to Feel Pressure from China's Free Trade Zones

The further development of China's new free trade zones (FTZs) is likely to affect Hong Kong's tourism industry in various ways, according to Ph.D. student Mingjie Ji, Associate Professor Mimi Li and Professor Brian King of the School of Hotel and ...
 Hospitality Net1 month ago

Full text: China's Progress in Poverty Reduction and Human Rights

BEIJING — China's State Council Information Office on Oct 17 issued a white paper on China's progress in poverty reduction and human rights. Following is the full text of the document. China's Progress in Poverty Reduction and Human Rights ...
 China Government1 month ago Progress in poverty reduction and human rights  CHINAdaily Europe1 month ago

Donations and Grants in China: Compliance Controls Beyond T&E

While travel and entertainment expenses have presented significant compliance challenges for life sciences companies operating in China, donations and grants can also pose notable compliance risks. China's escalated anti-corruption enforcement in ...
 JD Supra2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less